Schonfeld Strategic Advisors »

Denali Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.3M 226k 14.52
2024-06-30 $3.8M 163k 23.22
2023-12-31 $393k 18k 21.46
2017-12-31 $743k 48k 15.64

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Ethereum Tr SHS (ETHA)
Fidelity Wise Origin Bitcoin SHS (FBTC)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Broadcom (AVGO)
Ishares Tr Core S&p500 Etf (IVV)
Alibaba Group Hldg Sponsored Ads (BABA)
Union Pacific Corporation (UNP)
Tesla Motors (TSLA)
Marvell Technology (MRVL)
Boston Scientific Corporation (BSX)

View all positions for Schonfeld Strategic Advisors

Top funds holding Denali Therapeutics

BlackRock
Vanguard Group
Baillie Gifford & Co
FMR
T. Rowe Price Investment Management
Ubs Global Asset Management Americas
State Street Corporation
Temasek Holdings
Capital Research Global Investors
Baker Bros. Advisors
Alliancebernstein
Geode Capital Management
Crestline Management
Holocene Advisors
Point72 Asset Management

View all funds holding Denali Therapeutics